Asthma-COPD overlap syndrome in the US: A prospective population-based analysis of patient-reported outcomes and health care utilization

International Journal of COPD

Volumn 12, Issue , 2017, Pages 517-527

  Vaz Fragoso, Carlos A ^a,b   Murphy, Terrence E ^a   Agogo, George O ^a   Allore, Heather G ^a,c   McAvay, Gail J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Clinical Epidemiology Research Center   (United States)

^c YALE UNIVERSITY   (United States)

Author keywords

Activities of daily living; Disability; Mobility; Recreational; Social

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISABILITY; FEMALE; HEALTH CARE UTILIZATION; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; SHORT FORM 12; SOCIAL BEHAVIOR; UNITED STATES; AMBULATORY CARE; BED REST; COMPARATIVE STUDY; COST OF ILLNESS; ECONOMICS; EMERGENCY HEALTH SERVICE; HEALTH CARE PLANNING; HOSPITAL ADMISSION; HOSPITAL COST; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOPHYSIOLOGY; PATIENT-REPORTED OUTCOME; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TREATMENT OUTCOME; UTILIZATION; VERY ELDERLY; WALKING DIFFICULTY;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ASTHMA; BED REST; COST OF ILLNESS; DISABILITY EVALUATION; EMERGENCY MEDICAL SERVICES; FEMALE; HEALTH RESOURCES; HEALTH STATUS; HOSPITAL COSTS; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; MOBILITY LIMITATION; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT ADMISSION; PATIENT REPORTED OUTCOME MEASURES; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK ASSESSMENT; RISK FACTORS; SOCIAL BEHAVIOR; TREATMENT OUTCOME; UNITED STATES;

EID: 85012191757     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S121223     Document Type: Article

References (48)

1. Postma DS, Rabe KF. The asthma-COPD overlap syndrome. N Engl J Med. 2015;373(13):1241-1249.
2. Global Initiative for Asthma. Global strategy for asthma management and prevention (updated 2015). Available from: http://ginasthma.org/archived-reports/. Accessed December 07, 2016.
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2015). Available from: http://goldcopd. org/archived-reports/. Accessed December 07, 2016.
4. Moorman JE, Akinbami LJ, Bailey CM, et al. National Surveillance of Asthma: United States, 2001-2010. Vital Health Stat 3. 2012;(35):1-58.
5. Kosacz NM, Punturieri A, Croxton TL, et al. Chronic obstructive pulmonary disease among adults - United States, 2011. MMWR. 2012;61(46): 938-943.
6. Pleasants RA, Ohar JA, Croft JB, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD. 2014;11(3):256-266.
7. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009;64(8): 728-735.
8. de Marco R, Pesce G, Marcon A, et al. The coexistence of asthma and chronic obstructive pulmonary disease (COPD): prevalence and risk factors in young, middle aged and elderly people from the general population. PLoS One. 2013;8(5):e62985.
9. Papaiwannou A, Zarogoulidis P, Porpodis K, et al. Asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): current literature review. J Thorac Dis. 2014;6(1):S146-S151.
10. Barnes PJ. Asthma-COPD overlap. Chest. 2016;149(1):7-8.
11. Gibson PG, McDonald VM. Asthma-COPD overlap 2015: now we are six. Thorax. 2015;70(7):683-691.
12. Hardin M, Cho M, McDonald ML, et al. The clinical and genetic features of COPD-asthma overlap syndrome. Eur Respir J. 2014; 44(2):341-350.
13. Hirota N, Martin JG. Mechanisms of airway remodeling. Chest. 2013; 144(3):1026-1032.
14. de Nijs SB, Venekamp LN, Bel EH. Adult-onset asthma: is it really different? Eur Respir Rev. 2013;22(127):44-52.
15. Barrecheguren M, Esquinas C, Miravitlles M. The asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS): opportunities and challenges. Curr Opin Pulm Med. 2015;21(1):74-79.
16. Hardin M, Silverman EK, Barr RG, et al; COPDGene Investigators. The clinical features of the overlap between COPD and asthma. Respir Res. 2011;12:127.
17. Cosio BG, Soriano JB, López-Campos JL, et al; CHAIN Study. Defining the asthma-COPD overlap syndrome in a COPD cohort. Chest. 2016; 149(1):45-52.
18. Nielsen M, Bårnes CB, Ulrik CS. Clinical characteristics of the asthma- COPD overlap syndrome - a systematic review. Int J Chron Obstruct Pulmon Dis. 2015;10:1443-1454.
19. Ding B, DiBonaventura M, Karlsson N, Ling X. Asthma-chronic obstructive pulmonary disease overlap syndrome in the urban Chinese population: prevalence and disease burden using the 2010, 2012, and 2013 China National Health and Wellness Surveys. Int J Chron Obstruct Pulmon Dis. 2016;11:1139-1150.
20. Sorino C, Pedone C, Scichilone N. Fifteen-year mortality of patients with asthma-COPD overlap syndrome. Eur J Intern Med. 2016;34:72-77.
21. Kumbhare S, Pleasants R, Ohar JA, Strange C. Characteristics and prevalence of asthma/chronic obstructive pulmonary disease overlap in the United States. Ann Am Thorac Soc. 2016;13(6):803-810.
22. Tkacova R, Dai DLY, Vonk JM, et al. Airway hyperresponsiveness in chronic obstructive pulmonary disease: a marker of asthma-chronic obstructive pulmonary disease overlap syndrome? J Allergy Clin Immunol. Epub 2016 May 24.
23. Cosentino J, Zhao H, Hardin M, et al. Analysis of asthma-COPD overlap syndrome when defined on the basis of bronchodilator response and degree of emphysema. Ann Am Thorac Soc. 2016;13(9):1483-1489.
24. Lange P, Çolak Y, Ingebrigtsen TS, Vestbo J, Marott JL. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis. Lancet Respir Med. 2016;4(6):454-462.
25. Kauppi P, Kupiainen H, Lindqvist A, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011;48(3): 279-285.
26. Gross NJ. Chronic obstructive pulmonary disease outcome measurements: what’s important? What’s useful? Proc Am Thorac Soc. 2005; 2(4):267-271.
27. Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697-709.
28. Haughney J, Partridge MR, Vogelmeier C, et al. Exacerbations of COPD: quantifying the patient’s perspective using discrete choice modeling. Eur Respir J. 2005;26(4):623-629.
29. MEPS survey background. Rockville, MD: Agency for Healthcare Research and Quality. Available from: http://www.meps.ahrq.gov/mepsweb/about_meps/survey_back.jsp. Accessed March 17, 2016.
30. Vaz Fragoso CA, McAvay G, Van Ness PH, et al. Phenotype of spirometric impairment in an aging population. Am J Respir Crit Care Med. 2016;193(7):727-735.
31. Kroenke K, Spitzer RL, Williams JBW. The patient health question-naire-2: validity of a two-item depression screener. Med Care. 2003; 41(11):1284-1292.
32. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
33. Ferguson GT, Enright PL, Buist AS, Higgins MW. Office spirometry for lung health assessment in adults: a consensus statement from the National Lung Health Education Program. Chest. 2000;117(4):1146-1161.
34. Nishi SP, Wang Y, Kuo YF, Goodwin JS, Sharma G. Spirometry use among older adults with chronic obstructive pulmonary disease: 1999-2008. Ann Am Thorac Soc. 2013;10:565-573.
35. Joo MJ, Sharp LK, Au DH, Lee TA, Fitzgibbon ML. Use of spirometry in the diagnosis of COPD: a qualitative study in primary care. COPD. 2013;10(4):444-449.
36. Allen SC, Yeung P. Inability to draw intersecting pentagons as a predictor of unsatisfactory spirometry technique in elderly hospital inpatients. Age Ageing. 2006;35(3):304-316.
37. Fried TR, Vaz Fragoso CA, Rabow MW. Caring for the older person with chronic obstructive pulmonary disease. JAMA. 2012;308(12): 1254-1263.
38. Vaz Fragoso CA, McAvay G, Gill TM, Concato J, Quanjer PH, Van Ness PH. Ethnic differences in respiratory impairment. Thorax. 2014;69(1):55-62.
39. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(5):446-451.
40. Vaz Fragoso CA, Gill TM, McAvay G, Quanjer PH, Van Ness PH, Concato J. Respiratory impairment in older persons: when less means more. Am J Med. 2013;126(1):49-57.
41. Vaz Fragoso CA, McAvay G, Van Ness PH, et al. Phenotype of normal spirometry in an aging population. Am J Respir Crit Care Med. 2015; 192(7):817-825.
42. Stanojevic S, Wade A, Stocks J, et al. Reference ranges for spirometry across all ages: a new approach. Am J Respir Crit Care Med. 2008; 177(3):253-260.
43. Quanjer PH, Stanojevic S, Cole TJ, et al. Multi-ethnic reference values for spirometry for the 3-95 year age range: the global lung function 2012 equations. Eur Respir J. 2012;40(6):1324-1343.
44. Pellegrino R, Antonelli A, Mondino M. Bronchodilator testing: an endless story. Eur Respir J. 2010;35(5):952-954.
45. Ghebre MA, Bafadhel M, Desai D, et al. Biological clustering supports both “Dutch” and “British” hypotheses of asthma and chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2015;135(1):63-72.
46. Bihlet AR, Karsdal MA, Bay-Jensen AC, et al. Clinical drug development using dynamic biomarkers to enable personalized health care in COPD. Chest. 2015;148(1):16-23.
47. Gauthier M, Ray A, Wenzel SE. Evolving concepts of asthma. Am J Respir Crit Care Med. 2015;192(6):660-668.
48. Soler-Cataluna JJ, Cosío B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol. 2012;48(9):331-337.